Literature DB >> 21955603

Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.

Miki Ohe1, Tomoyuki Yokose, Yuji Sakuma, Sachie Osanai, Chikako Hasegawa, Kota Washimi, Kimitoshi Nawa, Tetsukan Woo, Rurika Hamanaka, Haruhiko Nakayama, Yoichi Kameda, Kouzo Yamada, Takeshi Isobe.   

Abstract

Generally, adenocarcinomas with micropapillary pattern, featuring small papillary tufts lacking a central fibrovascular core, are thought to have poor prognosis. This pattern has been described in various organs. However, tumor cells with micropapillary pattern of lung adenocarcinoma are more often seen to float within alveolar spaces (aerogenous micropapillary pattern, AMP) than in fibrotic stroma like other organs (stromal micropapillary pattern, SMP) and SMP predominant lung adenocarcinoma (SMPPLA) has not been well described yet. We presented two cases of SMPPLA which were found in the last four years. Both the cases showed more than 50% of SMP in the tumor area. The majority of the stromal micropapillary clusters expressed MUC1 and epithelial membrane antigen along the outer surface of cell membrane. On the other hand, connective tissues surrounding stromal micropapillary clusters showed no reactivity for epithelial markers (thyroid transcription factor-1 and cytokeratin) or endothelial marker (D2-40 and CD34). It means clusters of SMP do not exist within air space or lymphatic or vessel lumens. The tumors with SMP often presented lymphatic permeation and vessel invasion, and intriguingly, one of the two cases showed metastasis to the mediastinal lymph node. Additionally, both the cases showed EGFR point mutations of exon 21. These results suggest that SMPPLA might be associated with poor prognosis and effective for EGFR tyrosine kinase inhibitors.

Entities:  

Mesh:

Year:  2011        PMID: 21955603      PMCID: PMC3212918          DOI: 10.1186/1746-1596-6-92

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  21 in total

1.  Rapid and simple detection of hot spot point mutations of epidermal growth factor receptor, BRAF, and NRAS in cancers using the loop-hybrid mobility shift assay.

Authors:  Shoichi Matsukuma; Mitsuyo Yoshihara; Fumio Kasai; Akinori Kato; Akira Yoshida; Makoto Akaike; Osamu Kobayashi; Haruhiko Nakayama; Yuji Sakuma; Tsutomu Yoshida; Yoichi Kameda; Eiju Tsuchiya; Yohei Miyagi
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

2.  Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.

Authors:  R T Burks; M E Sherman; R J Kurman
Journal:  Am J Surg Pathol       Date:  1996-11       Impact factor: 6.394

3.  Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma.

Authors:  Mi-Jung Kim; Seung-Mo Hong; Se J Jang; Eunsil Yu; Jung-Sun Kim; Kyu-Rae Kim; Gyungyub Gong; Jae Y Ro
Journal:  Hum Pathol       Date:  2006-07       Impact factor: 3.466

4.  Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival.

Authors:  Sayaka Kuba; Hiroshi Ohtani; Junzo Yamaguchi; Hiroko Hayashi; Tatsuya Uga; Takashi Kanematsu; Isao Shimokawa
Journal:  Virchows Arch       Date:  2011-01-08       Impact factor: 4.064

5.  Primary invasive micropapillary carcinoma of the colon.

Authors:  K Sakamoto; M Watanabe; C De La Cruz; H Honda; H Ise; K Mitsui; K Namiki; Y Mikami; T Moriya; H Sasano
Journal:  Histopathology       Date:  2005-11       Impact factor: 5.087

6.  Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.

Authors:  Ankur R Sangoi; Andrew H Beck; Mahul B Amin; Liang Cheng; Jonathan I Epstein; Donna E Hansel; Kenneth A Iczkowski; Antonio Lopez-Beltran; Esther Oliva; Gladell P Paner; Victor E Reuter; Jae Y Ro; Rajal B Shah; Steven S Shen; Pheroze Tamboli; Jesse K McKenney
Journal:  Am J Surg Pathol       Date:  2010-09       Impact factor: 6.394

7.  Bile duct adenocarcinoma with minor micropapillary component: a case report.

Authors:  Takeshi Kondo
Journal:  Cases J       Date:  2009-01-14

8.  Primary invasive micropapillary carcinoma of the stomach.

Authors:  Masayuki Shimoda; Yasunori Okada; Yuichiro Hayashi; Satoshi Hatano; Hirofumi Kawakubo; Tai Omori; Seiichiro Ishii; Hitoshi Sugiura
Journal:  Pathol Int       Date:  2008-08       Impact factor: 2.534

9.  Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.

Authors:  Hidetaka Yamamoto; Hideoki Uryu; Yuichi Segawa; Masazumi Tsuneyoshi
Journal:  Pathol Int       Date:  2008-05       Impact factor: 2.534

10.  On the significance of Surfactant Protein-A within the human lungs.

Authors:  Torsten Goldmann; Daniel Kähler; Holger Schultz; Mahdi Abdullah; Dagmar S Lang; Florian Stellmacher; Ekkehard Vollmer
Journal:  Diagn Pathol       Date:  2009-03-12       Impact factor: 2.644

View more
  2 in total

1.  Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma.

Authors:  Miki Ohe; Tomoyuki Yokose; Yuji Sakuma; Yohei Miyagi; Naoyuki Okamoto; Sachie Osanai; Chikako Hasegawa; Haruhiko Nakayama; Yoichi Kameda; Kouzo Yamada; Takeshi Isobe
Journal:  Diagn Pathol       Date:  2012-01-06       Impact factor: 2.644

2.  IMP3 can predict aggressive behaviour of lung adenocarcinoma.

Authors:  Renata Beljan Perak; Merica Glavina Durdov; Vesna Capkun; Veljka Ivcevic; Antonia Pavlovic; Violeta Soljic; Mari Peric
Journal:  Diagn Pathol       Date:  2012-11-28       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.